Electrolysed Saline Rinse As an Adjunct for Treatment of Chronic Periodontitis
EOSPERIO
Influence of Adjunctive Electrolysed Saline Rinse in Stage III Periodontitis Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
The study will be conducted as a prospective, double-blind, parallel, randomized, placebo-controlled study at the Dental Clinic of University Medical Centre Ljubljana. It will involve a one-month test period, during which the test subjects will use either placebo, Electrolysed Oxidising Saline (EOS) or chlorhexidine (CHX) in the form of a mouthwash as an adjunct to the non-surgical treatment of chronic periodontitis (i.e. root planing and scaling). We will include 60 subjects who will be selected from consecutively scheduled patients referred by their personal dentists for periodontal treatment at the Dental Clinic of University Medical Centre Ljubljana.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2024
CompletedFirst Submitted
Initial submission to the registry
November 14, 2024
CompletedFirst Posted
Study publicly available on registry
November 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2026
ExpectedNovember 18, 2024
November 1, 2024
1.5 years
November 14, 2024
November 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
No of residual diseased sites
Probing Pocket Depth (PPD) \> 4 mm + Bleeding On Probing (BOP)
Baseline, 1 month, 3 months
Secondary Outcomes (3)
Probing Pocket Depth (PPD)
Baseline, 1 month, 3 months
Clinical Attachment Level (CAL)
Baseline, 1 month, 3 months
Full Mouth Plaque Score (FMPS)
Baseline, 1 month, 3 months
Other Outcomes (1)
Absolute number and share of 14 periodontopathogenic species
Baseline, 1 month, 3 months
Study Arms (3)
EOS
EXPERIMENTALCHX
ACTIVE COMPARATORPlacebo - distilled water
PLACEBO COMPARATORInterventions
EOS ph = 7, 200 ppm free available Chlorine
Eligibility Criteria
You may qualify if:
- Clinical attachment loss ≥ 5 mm on at least two teeth in two different jaw quadrants; presence of stable occlusion and at least 16 teeth, among which at least 12 teeth are suitable for evaluation (excluding wisdom teeth, teeth with orthodontic wires, bridges, crowns, and implants).
You may not qualify if:
- We will exclude individuals who: suffer from chronic systemic diseases (diabetes, cancer, HIV infection, metabolic bone diseases, and diseases that interfere with wound healing processes); are undergoing radiation or chemotherapy; are taking immunosuppressants, antiepileptic drugs, calcium antagonists, nonsteroidal anti-inflammatory drugs; have been treated with antibiotics in the past 12 months; have a known allergy to CHX; have undergone scaling and root planing or surgical periodontal treatment in the past year; are pregnant or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Randomization will be performed using a computer program. Only one member of the research group, who will also prepare the mouthwashes, will know the content of the randomization table or the type of mouthwash used by each individual. Identification codes will remain hidden from all other researchers and subjects until the final follow-up examinations. The packaging of the mouthwashes will be identical, and the active ingredients will not be distinguishable by color.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2024
First Posted
November 18, 2024
Study Start
June 6, 2024
Primary Completion
December 6, 2025
Study Completion (Estimated)
December 6, 2026
Last Updated
November 18, 2024
Record last verified: 2024-11